NJ Residents Urged to Redeem Funds Invested with GS Partners Following Agreement Resolving Multistate Securities Investigation

NJ Residents Entitled to Full Refund of Assets Invested in Securities Tied to Digital Assets and Metaverse Technology For Immediate Release: November 4, 2024 Office of the Attorney General- Matthew J. Platkin, Attorney GeneralDivision of Consumer Affairs- Cari...

Attorney General Platkin Announces Cooperation Agreements, Settlements with Two Generic Drug Firms

Multistate Lawsuits Alleged Conspiracies to Inflate Drug Prices and Limit Competition For Immediate Release: November 1, 2024 Office of the Attorney General- Matthew J. Platkin, Attorney GeneralDivision of Consumer Affairs- Cari Fais, DirectorDivision of Law- Michael...

Cari Fais Confirmed as First Latina Director of the New Jersey Division of Consumer Affairs

Attorney General Matthew J. Platkin today announced the confirmation of Cari Fais as the Director of the Division of Consumer Affairs (“Division”).

AG Platkin, Division of Consumer Affairs Announce New Rules Aimed at Promoting Greater Transparency in Prescription Drug Pricing, Including How and Why Prices Are Increased

Advancing the Murphy Administration’s efforts to rein in the high cost of prescription drugs in New Jersey, Attorney General Matthew J. Platkin and the Division of Consumer Affairs (“Division”) announced specially adopted new rules promoting greater transparency in prescription drug pricing.

Attorney General Platkin, Multistate Coalition Announce $52 Million Settlement for Marriott, Starwood Data Breaches

Attorney General Matthew J. Platkin and the Division of Consumer Affairs announced that a coalition of 50 Attorneys General reached a $52 million settlement with Marriott International, Inc. to resolve investigations concerning two information security failures, including one widespread data breach.

AG Platkin, Division on Civil Rights File Complaint in Superior Court Against Virtua Health for Alleged Discrimination Against Pregnant Patients

Hospital Mandates Universal Drug Testing of Pregnant Patients, Conducts Drug Tests Without Obtaining Informed Consent.

Translate »